S

Sobi

Develops therapies for rare diseases

Director Commercial Strategy and Business Development Assessment

Corporate StrategyConfirmed live in the last 24 hours
Full-timeWaltham, MA, USARemote

About the Job

Requirements

  • A bachelor's degree is required.
  • Eight to ten or more years of progressive pharmaceutical, biotechnology, healthcare consulting, commercial strategy, commercial development, market access, portfolio strategy, or business development experience are required.
  • Experience conducting commercial due diligence, portfolio assessments, strategic business analyses, or asset evaluations is required.
  • Specialty pharmaceutical or biotechnology experience is required.
  • Experience evaluating assets across multiple therapeutic areas is required.
  • Experience developing commercial assessments supporting acquisition, licensing, portfolio investment, launch planning, or commercialization decisions is required.
  • Experience assessing commercial opportunities through pricing, reimbursement, market access, commercialization requirements, operating model design, and launch readiness is required.
  • Strong understanding of pharmaceutical pricing, reimbursement, market access, commercialization, and portfolio evaluation principles is required.
  • Strong analytical and quantitative skills are required.
  • Executive communication and presentation skills are required.
  • Ability to influence without direct authority is required.

Responsibilities

  • Lead U.S. commercial assessments for acquisition, licensing, partnership, and strategic business development opportunities.
  • Evaluate strategic fit, unmet need, treatment paradigms, competitive intensity, market attractiveness, and long-term commercial potential.
  • Support internal portfolio strategy initiatives, including new indications, lifecycle management opportunities, reformulations, and line extensions.
  • Develop recommendations regarding commercial viability, launch feasibility, investment requirements, organizational implications, and key risks.
  • Assess alignment with corporate strategy and long-term growth objectives.
  • Lead commercial due diligence activities.
  • Assess epidemiology, diagnosed populations, treated populations, addressable patient populations, treatment algorithms, and site-of-care dynamics.
  • Develop market sizing methodologies and opportunity assessments.
  • Conduct primary and secondary research to validate assumptions.
  • Partner with Business Analytics to validate epidemiology, patient opportunity, and forecast inputs.
  • Evaluate competitive landscapes, pipeline threats, and future market evolution.
  • Participate in diligence meetings with target companies and consultants.
  • Develop pricing recommendations and commercial pricing frameworks.
  • Evaluate pricing potential relative to clinical differentiation and payer expectations.
  • Develop gross-to-net assumptions and reimbursement frameworks.
  • Assess Medicare, Medicaid, Commercial, Specialty Pharmacy, and Buy-and-Bill reimbursement implications.
  • Evaluate payer management expectations, utilization management risks, and access barriers.
  • Assess coding, payment, contracting, distribution, and channel considerations.
  • Support assessment of evolving healthcare policy initiatives and their potential impact on commercial opportunity, pricing strategy, reimbursement, and long-term asset value.
  • Partner with Market Access leadership to evaluate policy developments related to GLOBE, GUARD, GENEROUS, MFN initiatives, and other pricing and reimbursement reform efforts.
  • Support NPC-related activities and monitor emerging policy developments and potential business implications.
  • Develop analyses evaluating policy-related risks and opportunities associated with acquisition, licensing, and portfolio opportunities.
  • Support scenario planning exercises assessing policy impacts on pricing, reimbursement, access, contracting, and commercialization assumptions.
  • Collaborate with Market Access subject matter experts to incorporate policy considerations into asset evaluations and strategic recommendations.
  • Develop commercialization strategies and launch planning recommendations.
  • Assess launch feasibility and organizational capabilities required for commercialization.
  • Develop recommendations regarding sales force size, deployment models, targeting strategies, and customer engagement approaches.
  • Assess patient support services, HUB operations, field reimbursement, nurse educator requirements, specialty pharmacy support, and distribution strategies.
  • Partner with Finance to develop commercialization investment assumptions and operating expense estimates.
  • Develop build-versus-buy recommendations and organizational capability assessments.
  • Support Market Access integration planning activities for acquired, licensed, or partnered assets.
  • Serve as the primary Market Access liaison to the central integration management team for assigned opportunities.
  • Develop recommendations regarding Market Access integration requirements, including pricing, reimbursement, patient support, contracting, distribution, field reimbursement, and access strategy considerations.
  • Partner with cross-functional stakeholders to identify integration risks, capability gaps, resource requirements, and implementation timelines.
  • Support development of integration workplans and readiness assessments.
  • Coordinate Market Access deliverables associated with integration activities and commercialization planning.
  • Monitor progress against integration milestones and support issue identification and resolution.
  • Develop recommendations regarding future-state operating models and organizational requirements for integrated assets.
  • Develop commercial assumptions related to pricing, reimbursement, access, uptake, competitive response, and lifecycle opportunities.
  • Support scenario planning and sensitivity analyses.
  • Partner with Finance and Business Development to refine revenue assumptions and investment scenarios.
  • Assess clinical differentiation, value proposition strength, and competitive positioning.
  • Evaluate evidence requirements necessary to support reimbursement and adoption.
  • Identify evidence gaps impacting commercial success.
  • Partner across Business Development, Commercial, Market Access, Medical Affairs, Business Analytics, Finance, Regulatory, and Legal.
  • Support leadership decision-making through objective, data-driven recommendations.

Desired Qualifications

  • An MBA, MPH, PharmD, PhD, or equivalent advanced degree is preferred.
  • Rare disease experience is strongly preferred.
  • Experience developing commercialization plans, operating models, sales force assumptions, patient support strategies, and launch readiness assessments is preferred.
  • Experience evaluating healthcare policy developments and assessing implications for pharmaceutical pricing, reimbursement, market access, and commercial strategy is preferred.
  • Experience supporting commercial integration, launch readiness, acquisition integration, or portfolio transition activities is preferred.
  • Experience working with cross-functional integration teams and organizational change initiatives is preferred.

About the Company

Sobi

Develops therapies for rare diseases

Sobi specializes in developing and delivering therapies for rare diseases. It focuses on hematology, immunology, and specialty care, bringing medicines to patients who have limited treatment options. Their products are designed to treat rare conditions and are typically administered by prescription under medical supervision; the company collaborates with partners to advance research, develop, and commercialize these therapies. Sobi differentiates itself through its strong biotechnological foundation from its Biovitrum heritage and a track record of strategic collaborations with major pharmaceutical players like Sanofi and Apellis, which expand its research capabilities and reach. The company’s goal is to improve the lives of patients with rare diseases worldwide by creating and delivering effective treatments that address unmet medical needs.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Solna kommun, Sweden
Founded
1988

Recently Posted Jobs

Explore more opportunities at Sobi

See more jobs